GAGE12C: A Potential Drug Target and Biomarker (G729422)

Target Name: GAGE12C

NCBI ID: G729422

GAGE12C

GAGE12C: A Potential Drug Target and Biomarker

GAGE12C, also known as g antigen 12C/D/E, is a protein that is expressed in various tissues of the body, including the skin, hair, and nails. It is a member of the GAGEA family of proteins, which are known for their role in cell-signaling and inflammation. GAGE12C has been identified as a potential drug target and biomarker due to its unique structure and expression pattern in various tissues.

The GAGEA family of proteins was first identified in the 1980s by researchers who were studying the cell-signaling pathways that were involved in the regulation of growth and development. These proteins are characterized by the presence of a unique domain that includes a conserved alpha helix structure and a highly conserved 尾-sheet. This domain is known as the N-terminal transmembrane domain (NTD), and it is responsible for the protein's ability to interact with various signaling molecules and for its role in intracellular signaling.

GAGE12C is a member of the GAGEA family and is expressed in various tissues of the body, including the skin, hair, and nails. It is characterized by a unique structure that includes a NTD, a transmembrane domain (TMD), and a cytoplasmic tail . The NTD is the unique feature of GAGE12C that gives it its unique structure and function.

The NTD is responsible for the regulation of the protein's stability and for its role in intracellular signaling. It is known to play a role in the regulation of cell-cycle progression, cell survival, and cell-signaling pathways. The NTD is also involved in the regulation of adhesion and in the regulation of the cytoskeleton.

GAGE12C has also been shown to be involved in the regulation of inflammation. It is known to play a role in the regulation of T-cell development and in the regulation of response. GAGE12C is also involved in the inflammation regulation of pain perception and in the regulation of neurogenesis.

GAGE12C has also been identified as a potential drug target due to its unique structure and expression pattern. The NTD is the most conserved domain in the GAGEA family, which makes it an attractive target for drug development. Additionally, GAGE12C is expressed in various tissues of the body, which makes it an attractive biomarker for drug development.

In conclusion, GAGE12C is a unique protein that is expressed in various tissues of the body. It is a member of the GAGEA family of proteins and is characterized by its unique structure, including a NTD, TMD, and cytoplasmic tail. GAGE12C has been shown to play a role in the regulation of various biological processes, including cell-signaling, inflammation, and pain perception. Its unique structure and expression pattern make it an attractive target for drug development and a potential biomarker. Further research is needed to fully understand the function and potential of GAGE12C as a drug target and biomarker.

Protein Name: G Antigen 12C

The "GAGE12C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GAGE12C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets